Studies The Crohn's & Colitis Foundation (CCFA) fosters and supports programs of basic research, clinical trials, observational studies and education projects as they relate to its mission to cure Crohn's disease and ulcerative colitis and to improve the quality of life of children and adults affected by these diseases.
You may be familiar with classic treatment studies, which involve administering a treatment (or placebo) to test the efficacy of a new medication. These therapeutic (or treatment) studies can be found on the CCFA website www.ccfa.org and are critical for testing potentially new inflammatory bowel disease (IBD) treatments. What you may not be aware of is that treatment studies are only one of many types of research studies that complete our understanding of inflammatory bowel diseases. The non-therapeutic (non-treatment) studies on this page represent studies that recruit inflammatory bowel disease patients or relatives of patients to study a wide-spectrum of specific questions related to inflammatory bowel diseases, other than the efficacy of a specific treatment. Since these studies do not involve the administration of a treatment of IBD, they often do not provide a direct potential benefit for an individual's treatment of IBD now. Even so, the information gained by participation in these studies is often critical and necessary for advancing our understanding of IBD and improving its management in the future. The Crohn's & Colitis Foundation (CCFA) will provide links to Crohn's disease and ulcerative colitis (non-therapeutic) studies that have statements of compliance with Health Insurance Portability and Accountability Act (HIPAA) regulations and that require informed consent from participants. The information provided on specific studies does not represent a CCFA endorsement of a particular study, group, company, health institution or product. To view current available studies please see below. Autoimmune Diseases in Pregnancy Study CCFA Partners Coping with Inflammatory Bowel Disease Cancer Surveillance and Risk Management Examining the Relationship of Resilience and Societal cost of Chronic Illness Investigation of the role of Substance P/NK1 Receptor System in IBD, IBS and Natural Variability in Pain Sensitivity Among Healthy Individuals. For information on posting a study, please review our study guidelines. updated 07/14/10 |
